Endogene Ltd. is an Australian-based medical device technology company with a vision to be a leading and long-term developer and innovator of novel treatments, medical devices, and management solutions, incubating and nurturing technologies from invention through to commercialisation in global markets. Endogene has developed and fully prototyped four medical device technologies, all of which are seen as potentially "disruptive", that is, they have an ability to have a major impact on existing products and treatment modalities in major markets. Each of Endogene's technologies represents a new generation device with unique features. Extensive investigation of other relevant products, markets and patents have confirmed the uniqueness and potential of Endogene's products. The key driver of the company and its value is the Parascope sngle-use self-propelling endoscope platform, incorporating Endogene's proprietary Fluid Kinetic Propulsion technology, which enables unprecedented, rapid and reliable access to the entire gastrointestinal tract. This technology eliminates the need to "push" the endoscope and facilitates the manufacture of cost-competitive, single-use, all-sterile, recyclable endoscopes which, eliminate the risk of cross-contamination associated with reusable endoscopes. Single-use gastrointestinal endoscopes are the future, creating a multi-billion dollar global market whilst eliminating cross-contamination, infection and deaths caused by reusable endoscopes. For further information, visit www.endogene.com.au